The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II–III Colorectal Cancer Patients After Curable Resection

References

• National Health Commission of the People’s Republic of C.. [Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer (2020 edition)]. Zhonghua Wai Ke Za Zhi. 2020;58(8):561–585.
   PubMedGoogle Scholar
• Kudose Y, Shida D, Ahiko Y, et al. Evaluation of recurrence risk after curative resection for patients with stage i to iii colorectal cancer using the hazard function: retrospective analysis of a single-institution large cohort. Ann Surg. 2020;Publish Ahead of Print. doi:10.1097/SLA.0000000000004058
   Google Scholar
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–771. doi:10.1038/nrc3611
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and Cancer: triggers, Mechanisms, and Consequences. Immunity. 2019;51(1):27–41.
   PubMed Web of Science ®Google Scholar
• Brennan CA, Garrett WS. Gut Microbiota, Inflammation, and Colorectal Cancer. Annu Rev Microbiol. 2016;70(1):395–411. doi:10.1146/annurev-micro-102215-095513
   PubMedGoogle Scholar
• Chen J, Pitmon E, Wang K. Microbiome, inflammation and colorectal cancer. Semin Immunol. 2017;32:43–53. doi:10.1016/j.smim.2017.09.006
   PubMed Web of Science ®Google Scholar
• Li S-Q, You X-H, Sun F, et al. Albumin to fibrinogen ratio and fibrinogen to pre-albumin ratio are economical, simple and promising prognostic factors for solid malignancy. J Thorac Dis. 2019;11(Suppl S15):S2036–S2038. doi:10.21037/jtd.2019.08.96
   PubMedGoogle Scholar
• Chen Q-G, Zhang L, Sun F, et al. Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients. Aging. 2019;11(6):1716–1732. doi:10.18632/aging.101864
   PubMedGoogle Scholar
• Wuhao H, Shengguang W, Hua Z, Bin Z, Changli W. Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer. Cancer Biol Med. 2018;15(1):88–96. doi:10.20892/j.issn.2095-3941.2017.0124
   PubMed Web of Science ®Google Scholar
• Park S, Ahn HJ, Yang M, Kim JA, Kim JK, Park SJ. The prognostic nutritional index and postoperative complications after curative lung cancer resection: A retrospective cohort study. J Thorac Cardiovasc Surg. 2020;160(1):276–285. doi:10.1016/j.jtcvs.2019.10.105
   PubMed Web of Science ®Google Scholar
• Salati M, Filippi R, Vivaldi C, et al. The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. Liver Int. 2020;40(3):704–711. doi:10.1111/liv.14314
   PubMed Web of Science ®Google Scholar
• Hu X, Shao Y-X, Yang Z-Q, Dou W-C, Xiong S-C, Li X. Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis. Cancer Cell Int. 2020;20(1):222. doi:10.1186/s12935-020-01320-w
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Tsujimoto H, Hiraki S, et al. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer. Ann Surg Oncol. 2018;25(11):3288–3299. doi:10.1245/s10434-018-6651-y
   PubMed Web of Science ®Google Scholar
• Abe S, Kawai K, Nozawa H, et al. LMR predicts outcome in patients after preoperative chemoradiotherapy for stage II-III rectal cancer. J Surg Res. 2018;222:122–131. doi:10.1016/j.jss.2017.09.053
   PubMed Web of Science ®Google Scholar
• Ying H-Q, Deng Q-W, He B-S, et al. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol. 2014;31(12):305. doi:10.1007/s12032-014-0305-0
   PubMed Web of Science ®Google Scholar
• Sun F, Peng H-X, Gao Q-F, et al. Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients. Cancer Manag Res. 2018;10:2151–2161. doi:10.2147/CMAR.S167398
   PubMed Web of Science ®Google Scholar
• Watt DG, Proctor MJ, Park JH, Horgan PG, McMillan DC, Grivennikov S. The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers. PLoS One. 2015;10(11):e0142159. doi:10.1371/journal.pone.0142159
   PubMed Web of Science ®Google Scholar
• Shibutani M, Maeda K, Nagahara H, et al. The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer. BMC Cancer. 2015;15:521.
   PubMed Web of Science ®Google Scholar
• Climent M, Ryan ÉJ, Stakelum Á, et al. Systemic inflammatory response predicts oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient colorectal cancer. Int J Colorectal Dis. 2019;34(6):1069–1078. doi:10.1007/s00384-019-03274-6
   PubMed Web of Science ®Google Scholar
• Dolan RD, McSorley ST, Park JH, et al. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Br J Cancer. 2018;119(1):40–51. doi:10.1038/s41416-018-0095-9
   PubMed Web of Science ®Google Scholar
• Chan JCY, Chan DL, Diakos CI, et al. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Ann Surg. 2017;265(3):539–546. doi:10.1097/SLA.0000000000001743
   PubMed Web of Science ®Google Scholar
• Li X, An B, Zhao Q, et al. Combined fibrinogen and neutrophil–lymphocyte ratio as a predictive factor in resectable colorectal adenocarcinoma. Cancer Manag Res. 2018;10:6285–6294. doi:10.2147/CMAR.S161094
   PubMed Web of Science ®Google Scholar
• Yatabe S, Eto K, Haruki K, et al. Signification of Systemic Immune-Inflammation Index for prediction of prognosis after resecting in patients with colorectal cancer. Int J Colorectal Dis. 2020;35(8):1549–1555. doi:10.1007/s00384-020-03615-w
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Okabayashi K, Hasegawa H, et al. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer. Ann Surg. 2018;267(3):527–531. doi:10.1097/SLA.0000000000002115
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li S-Q, Liao Z-H, et al. Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer. Oncotarget. 2017;8(43):75195–75205. doi:10.18632/oncotarget.20661
   PubMedGoogle Scholar
• Zhang L, Chen Q-G, Li S-Q, et al. Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinoma. Future Oncol. 2019;15(1):13–22. doi:10.2217/fon-2018-0376
   PubMed Web of Science ®Google Scholar
• Kwaan HC, Lindholm PF. Fibrin and Fibrinolysis in Cancer. Semin Thromb Hemost. 2019;45(4):413–422. doi:10.1055/s-0039-1688495
   PubMed Web of Science ®Google Scholar
• Fanali G, Di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33(3):209–290. doi:10.1016/j.mam.2011.12.002
   PubMed Web of Science ®Google Scholar
• Yap SH, Moshage HJ, Hazenberg BP, et al. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes. Biochim Biophys Acta. 1991;1091(3):405–408. doi:10.1016/0167-4889(91)90207-E
   PubMedGoogle Scholar
• Scheede-Bergdahl C, Watt HL, Trutschnigg B, et al. Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia? Clin Nutr. 2012;31(1):85–88. doi:10.1016/j.clnu.2011.07.010
   PubMed Web of Science ®Google Scholar
• Aaldriks AA, van der Geest LGM, Giltay EJ, et al. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol. 2013;4(3):218–226. doi:10.1016/j.jgo.2013.04.001
   PubMed Web of Science ®Google Scholar
• Hu W-H, Eisenstein S, Parry L, Ramamoorthy S. Preoperative malnutrition with mild hypoalbuminemia associated with postoperative mortality and morbidity of colorectal cancer: a propensity score matching study. Nutr J. 2019;18(1):33. doi:10.1186/s12937-019-0458-y
   PubMed Web of Science ®Google Scholar
• Umezawa S, Higurashi T, Komiya Y, et al. Chemoprevention of colorectal cancer: past, present, and future. Cancer Science. 2019;110(10):3018–3026. doi:10.1111/cas.14149
   PubMed Web of Science ®Google Scholar
• Drew DA, Cao Y, Chan AT. Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer. 2016;16(3):173–186.
   PubMed Web of Science ®Google Scholar